Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma (Q24300191)

GOA release 2020-03-11

Acid phosphatase 3

1 reference

phospholipid catabolic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Junken Aoki

5

0 references

author name string

Masayuki Tanaka

1

0 references

Yasuhiro Kishi

2

0 references

Yasukazu Takanezawa

3

0 references

Yoshiyuki Kakehi

4

0 references

Hiroyuki Arai

A family of phospholipid autacoids: occurrence, metabolism and bioactions

6

0 references

language of work or name

English

0 references

publication date

30 July 2004

0 references

published in

FEBS Letters

0 references

volume

571

0 references

issue

1-3

0 references

page(s)

197-204

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Molecular mechanisms of lysophosphatidic acid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

The emerging role of lysophosphatidic acid in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Lysophospholipid G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Lysophosphatidic acid, a growth factor-like lipid, in the saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: distinct molecular species compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Lipid analysis of human spermatozoa and seminal plasma by MALDI-TOF mass spectrometry and NMR spectroscopy - effects of freezing and thawing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Detection of 14-kDa group II phospholipase A2 in human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

An alternative splicing form of phosphatidylserine-specific phospholipase A1 that exhibits lysophosphatidylserine-specific lysophospholipase activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

The human alkaline phosphatases: what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Human prostatic acid phosphatase: selected properties and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Autotaxin, tumor motility-stimulating exophosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

The determination of choline in human semen by the enzymic method

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Effect of lysophosphatidic acid on the ovum transport in mouse oviducts

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Mitogenic action of LPA in prostate

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021

Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.06.083

7 January 2021